GlaxoSmithKline (GSK) will pay some doctors for promoting its drugs reversing its previous policy, sparking new calls for a US-style "Sunshine Act" requiring doctors to declare all payments
As uncertainty hangs over the availability of Vertex’s cystic fibrosis drug in England, the company has signed an agreement that gives Danish patients access to Orkambi.
The FDA has unveiled new guidance outlining how healthcare organisations can prepare their medical devices and staff in the event of a security breach.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
